129 related articles for article (PubMed ID: 8094571)
1. [Chronic obstructive pulmonary disease (COPD)].
Sasaki H; Itabashi S; Fukushima T; Sekizawa K
Kokyu To Junkan; 1993 Jan; 41(1):35-40. PubMed ID: 8094571
[No Abstract] [Full Text] [Related]
2. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
Restrepo RD
Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
[TBL] [Abstract][Full Text] [Related]
3. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
van Schayck CP; Postma DS; Lammers JW
Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
[TBL] [Abstract][Full Text] [Related]
4. Combined bronchodilator therapy in the management of chronic obstructive pulmonary disease.
Friedman M
Respirology; 1997; 2 Suppl 1():S19-23. PubMed ID: 9400691
[TBL] [Abstract][Full Text] [Related]
5. Monthly, daily, and circadian variations of measurements of pulmonary mechanics in horses with chronic obstructive pulmonary disease.
Jean D; Vrins A; Lavoie JP
Am J Vet Res; 1999 Nov; 60(11):1341-6. PubMed ID: 10566805
[TBL] [Abstract][Full Text] [Related]
6. Exercise limitation in chronic obstructive pulmonary disease (COPD).
D'Urzo AD
Am J Respir Crit Care Med; 1999 Aug; 160(2):756. PubMed ID: 10475696
[No Abstract] [Full Text] [Related]
7. [Therapy of obstructive respiratory tract diseases. I: Beta 2-sympathomimetic drugs and anticholinergic agents (m-cholinergic receptor blockers)].
Ukena D; Schlimmer P; Sybrecht GW
Med Klin (Munich); 1989 Jun; 84(6):294-302. PubMed ID: 2569161
[No Abstract] [Full Text] [Related]
8. Considerations in office management of chronic obstructive pulmonary disease.
Schwartz AM
J Am Osteopath Assoc; 1981 Aug; 80(12 Suppl):866-9. PubMed ID: 6115835
[No Abstract] [Full Text] [Related]
9. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive pulmonary disease].
Bootsma GP; Van Weel C; Van Herwaarden CL
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):764. PubMed ID: 10347634
[No Abstract] [Full Text] [Related]
10. COPD and beta-blockers.
Segal MS; MacDonnell KF
Compr Ther; 1982 Sep; 8(9):3-5. PubMed ID: 6128100
[No Abstract] [Full Text] [Related]
11. [Beta-2 agonists in the therapy of obstructive airway diseases].
Solèr M
Praxis (Bern 1994); 1996 Sep; 85(38):1159-61. PubMed ID: 8927893
[No Abstract] [Full Text] [Related]
12. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
Ulrik CS
Ugeskr Laeger; 1996 Jun; 158(25):3604-7. PubMed ID: 8693619
[TBL] [Abstract][Full Text] [Related]
13. [Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease].
Dorow P; Weiss T; Felix R; Schmutzler H
Arzneimittelforschung; 1987 Dec; 37(12):1378-81. PubMed ID: 3449066
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?
Subramanian D; Guntupalli KK
Postgrad Med; 1994 Jun; 95(8):69-70, 75-8, 83-5. PubMed ID: 8202424
[TBL] [Abstract][Full Text] [Related]
15. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
16. [Evaluation of hyperkinetic cardiac arrhythmia in chronic obstructive bronchopneumopathy].
Conte G; Lauro S; Lazzarin M; Rigon N; Perrone A
Minerva Cardioangiol; 1997 Sep; 45(9):429-33. PubMed ID: 9446064
[TBL] [Abstract][Full Text] [Related]
17. A systemic approach to the acute treatment of decompensated chronic obstructive pulmonary disease.
Larsen RF
J Indiana State Med Assoc; 1983 Apr; 76(4):256-60. PubMed ID: 6133897
[No Abstract] [Full Text] [Related]
18. [Chronic obstructive lung disease (COPD)].
Gillissen A; Rasche K
Med Klin (Munich); 2006 Jul; 101(7):559-70; quiz 571-2. PubMed ID: 16850172
[No Abstract] [Full Text] [Related]
19. [Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD].
Lode H
Internist (Berl); 1999 Jan; 40(1):114. PubMed ID: 10086312
[No Abstract] [Full Text] [Related]
20. [Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy].
Hahn HL
Verh Dtsch Ges Inn Med; 1988; 94():364-75. PubMed ID: 2905102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
